Showing results (941-950 of 1,615) with videos related to
Sort By:
Pageof 162
Cancer Journal (Sudbury, Mass.)|March 27, 2014
CD19-CAR trialsCarlos A Ramos, Barbara Savoldo, Gianpietro DottiCancer Journal (Sudbury, Mass.)|March 27, 2014
CD28z CARs and armored CARsHollie J Pegram, Jae H Park, Renier J BrentjensCancer Journal (Sudbury, Mass.)|March 27, 2014
Adoptive therapy with chimeric antigen receptor-modified T cells of defined subset compositionStanley R Riddell, Daniel Sommermeyer, Carolina Berger, et al.Cancer Journal (Sudbury, Mass.)|March 27, 2014
CAR T cells for solid tumors: armed and ready to go?Sunitha Kakarla, Stephen GottschalkCancer Journal (Sudbury, Mass.)|March 27, 2014
Novel approaches to enhance the specificity and safety of engineered T cellsVictor D Fedorov, Michel Sadelain, Christopher C KlossCancer Journal (Sudbury, Mass.)|November 22, 2016
Increasing Role of Image-Guided Ablation in the Treatment of Musculoskeletal TumorsAnil Nicholas Kurup, Matthew R CallstromCancer Journal (Sudbury, Mass.)|October 18, 2016
Clinical Validity of Detecting Circulating Tumor Cells by AdnaTest Assay Compared With Direct Detection of Tumor mRNA in Stabilized Whole Blood, as a Biomarker Predicting Overall Survival for Metastatic Castration-Resistant Prostate Cancer PatientsDaniel C Danila, Aliaksandra Samoila, Chintan Patel, et al.Cancer Journal (Sudbury, Mass.)|October 18, 2016
Androgen Receptor and Beyond, Targeting Androgen Signaling in Castration-Resistant Prostate CancerZachery R Reichert, Maha HussainCancer Journal (Sudbury, Mass.)|October 18, 2016
Prostate-Specific Membrane Antigen-Directed Therapy for Metastatic Castration-Resistant Prostate CancerMin Yuen Teo, Michael J MorrisCancer Journal (Sudbury, Mass.)|October 18, 2016
The Role of Next-Generation Sequencing in Castration-Resistant Prostate Cancer TreatmentDaniel H Hovelson, Scott A TomlinsPageof 162